SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
75 hedge funds and large institutions have $112M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
75
Holders Change
+17
Holders Change %
+29.31%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
22
Increased
21
Reduced
7
Closed
5
Calls
$162K
Puts
$3K
Net Calls
+$159K
Net Calls Change
-$516K
Top Buyers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$4.21M |
2 |
KCM
2
Kennedy Capital Management
St Louis,
Missouri
|
$2.17M |
3 |
3
Walleye Capital
New York
|
$1.52M |
4 |
4
Millennium Management
New York
|
$1.4M |
5 |
5
Goldman Sachs
New York
|
$2.39M |